or Try an Advanced Search...

    Technical Analysis for ABCL - AbCellera Biologics Inc.

    Grade Last Price % Change Price Change
    F 2.78 -6.08% -0.18
    ABCL closed down 6.08 percent on Monday, July 1, 2024, on 1.13 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ABCL trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion -6.08%
    Up 3 Days in a Row Strength -6.08%
    Oversold Stochastic Weakness -6.08%
    Outside Day Range Expansion -3.47%
    Wide Bands Range Expansion -3.47%
    Oversold Stochastic Weakness -3.47%
    Wide Bands Range Expansion -0.36%
    Oversold Stochastic Weakness -0.36%
    Older End-of-Day Signals for ABCL ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % about 9 hours ago
    Down 1% about 9 hours ago
    Fell Below 10 DMA about 9 hours ago
    2x Volume Pace 3 days ago
    1.5x Volume Pace 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ABCL Chart by TradingView
    Basic chart:

    Profile

    AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Disease Health Sciences Pharmacy Antibodies Medication Pharmacology Drug Development Pharmaceutical Sciences

    Is ABCL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 25 AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
    Jun 6 We're Not Very Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn Rate
    May 28 AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
    May 16 AbCellera: If You Build It, Will They Come? Fresh Impetus Required
    May 16 AbCellera: Cash Providing Shelter From Market Weakness
    May 10 Earnings Release: Here's Why Analysts Cut Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target To US$12.71
    May 8 AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript
    May 8 Q1 2024 Abcellera Biologics Inc Earnings Call
    May 8 AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript
    May 8 AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript
    See more ABCL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.05
    52 Week Low 2.71
    Average Volume 1,674,525
    200-Day Moving Average 4.52
    50-Day Moving Average 3.62
    20-Day Moving Average 3.23
    10-Day Moving Average 2.89
    Average True Range 0.17
    RSI (14) 28.06
    ADX 30.17
    +DI 15.51
    -DI 32.54
    Chandelier Exit (Long, 3 ATRs) 3.68
    Chandelier Exit (Short, 3 ATRs) 3.23
    Upper Bollinger Bands 3.99
    Lower Bollinger Band 2.47
    Percent B (%b) 0.21
    BandWidth 47.30
    MACD Line -0.27
    MACD Signal Line -0.25
    MACD Histogram -0.02
    Fundamentals Value
    Market Cap 806.67 Million
    Num Shares 290 Million
    EPS -0.44
    Price-to-Earnings (P/E) Ratio -6.32
    Price-to-Sales 30.92
    Price-to-Book 1.23
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.10
    Resistance 3 (R3) 3.13 3.05 3.04
    Resistance 2 (R2) 3.05 2.97 3.04 3.02
    Resistance 1 (R1) 2.92 2.92 2.88 2.89 3.01
    Pivot Point 2.84 2.84 2.83 2.83 2.84
    Support 1 (S1) 2.71 2.76 2.67 2.68 2.55
    Support 2 (S2) 2.63 2.71 2.62 2.54
    Support 3 (S3) 2.50 2.63 2.52
    Support 4 (S4) 2.47